Z85 — Personal history of malignant neoplasm
Part of Chapter 21: Factors influencing health status and contact with health services , block Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99) .
Official Notes
Code First
any follow-up examination after treatment of malignant neoplasm ( Z08 )
Use Additional Code
code to identify:
Use Additional Code
alcohol use and dependence ( F10 .-)
Use Additional Code
exposure to environmental tobacco smoke ( Z77.22 )
Use Additional Code
history of tobacco dependence ( Z87.891 )
Use Additional Code
occupational exposure to environmental tobacco smoke ( Z57.31 )
Use Additional Code
tobacco dependence ( F17 .-)
Use Additional Code
tobacco use ( Z72.0 )
Excludes2
personal history of benign neoplasm ( Z86.01- )
Excludes2
personal history of carcinoma-in-situ ( Z86.00- )
Child Codes
- Z85.0 Personal history of malignant neoplasm of digestive organs Has subcodes
- Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung Has subcodes
- Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs Has subcodes
- Z85.3 Personal history of malignant neoplasm of breast Billable
- Z85.4 Personal history of malignant neoplasm of genital organs Has subcodes
- Z85.5 Personal history of malignant neoplasm of urinary tract Has subcodes
- Z85.6 Personal history of leukemia Billable
- Z85.7 Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues Has subcodes
- Z85.8 Personal history of malignant neoplasms of other organs and systems Has subcodes
- Z85.9 Personal history of malignant neoplasm, unspecified Billable
Referenced By
Official notes on these codes cite Z85.
- Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm Billable
- Z15.0 Genetic susceptibility to malignant neoplasm
- Z86.0 Personal history of in-situ and benign neoplasms and neoplasms of uncertain behavior
- QA1 Genetic disorders associated with neoplasms, not elsewhere classified
FY 2027 effective October 1, 2026 · CDC NCHS and CMS